Pricing Log in Create free account

Odyssey Therapeutics, Inc. (ODTX) vs Pharming Group N.V. Sponsored ADR (PHAR)

Odyssey Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. Odyssey Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are of similar size ($907.3M and $870.6M). Odyssey Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 34.2×. Pharming Group N.V. Sponsored ADR has the higher net margin (6.27% vs 0.00%) and the higher return on invested capital (10.1% vs −238.8%). Across the 11 metrics below, Pharming Group N.V. Sponsored ADR leads on 8 and Odyssey Therapeutics, Inc. on 3.

Valuation

Metric ODTX PHAR Biotechnology median
P/E n/m 34.22 10.60
P/S n/m 2.23 9.40
P/B 2.44 2.96 2.13
Price to free cash flow n/m 25.00 25.18
EV/EBITDA n/m 17.39 0.66
EV/Sales n/m 2.00 9.02
Earnings yield (90.93%) 2.92% (32.88%)
Free cash flow yield (16.19%) 4.00% (23.13%)

Profitability

Metric ODTX PHAR Biotechnology median
Gross margin — 85.10% 68.51%
Operating margin 0.00% 8.40% 0.00%
Net margin 0.00% 6.27% 0.00%
Free cash flow margin 0.00% 8.92% 0.00%
Return on equity 0.00% 8.73% (51.96%)
Return on assets 0.00% 5.00% (46.06%)
Return on invested capital (238.81%) 10.07% 0.00%

Growth

Metric ODTX PHAR Biotechnology median
Revenue growth (TTM) — 6.76% 6.76%
EPS growth (last fiscal year) — 125.00% 29.88%
Revenue growth, 5-year CAGR — 12.13% 9.75%
Net income growth, 5-year CAGR — (40.35%) 0.00%

Health

Metric ODTX PHAR Biotechnology median
Debt to equity 0.00 0.34 0.00
Current ratio 12.94 3.23 4.97
Net debt to EBITDA — (2.21) 1.01

Dividend

Metric ODTX PHAR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ODTX PHAR Biotechnology median
Market cap 907.34m 870.59m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack